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Coronary artery bypass surgery (CABG) has undergone a host ofchanges since its initial description by Favaloro. Throughout theprogressive refinements of cardiopulmonary bypass technologies,myocardial protection strategies, and the rise in popularity ofoff-pump coronary bypass (OPCAB) and other techniques of “less-invasive” surgery, the actual technical aspects of creating a coro-
nary anastomosis have remained relatively constant. A new class of anastomotic
devices may change this process and, with it, some of our fundamental assumptions
about what is required to perform this operation.
Potential Advantages and Applications
Although the advantages of these anastomotic connectors have yet to be fully
realized in the first generation devices that are now available, their potential is
intriguing. Device manufacturers hope to enable the creation of anastomoses in
seconds, not minutes, with completely uniform geometry, reproducibility, and the
requirement for relatively little surgeon training. If proximal anastomoses can be
performed in 2 to 5 seconds and distal anastomoses in 1 to 2 minutes, our typical day
in the operating room may change dramatically! But faster anastomoses may have
greater benefits than getting us to lunch more quickly or enabling us to do more
cases. Reduced ischemic times, whether global or regional, may reduce myocardial
injury and improve operative outcomes. Quicker anastomoses and more rapid
reperfusion in patients having ongoing myocardial ischemia or infarction should
translate into greater myocardial salvage. The ability to perform distal anastomoses
rapidly may also facilitate the performance of OPCAB, when cardiac positioning
and stabilization must be maintained for only a fraction of the time that is now
necessary. Finally, in a health care environment in which cost containment is a
major imperative, reduced operating room times can improve an institution’s bottom
line.
The most intuitively attractive application of devices like the Symmetry Aortic
Connector System (St Jude Medical Anastomotic Technology Group, St Paul,
Minn),1 which creates a sutureless proximal saphenous vein graft anastomosis, is in
OPCAB. Although proponents of OPCAB frequently cite the deleterious effects of
cardiopulmonary bypass on postoperative neuropsychologic outcomes, the use of a
side-biting clamp during OPCAB procedures to construct proximal anastomoses
may dislodge particulate emboli and cause similar neurologic sequelae. The com-
plete elimination of aortic clamping from OPCAB surgery may be the only way in
which the purported neuropsychologic benefits of this technique may be demon-
strable. Although early experience with these connectors has been promising,2,3
their potential in this regard has yet to be proven.
Another application in which anastomotic devices may be advantageous is in
minimal-access CABG. The use of robotic telemanipulation to perform sutured
coronary anastomoses in a closed chest requires expensive equipment, extreme
patience, and a significant learning curve. Although advances in robotic technology
continue, its ability to simplify CABG remains unclear. This is an area, however, in
which anastomotic devices may prove invaluable. Sutureless connectors may rep-
resent the enabling technology that allows minimal-access CABG to become more
than a curiosity.
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Potential Drawbacks and the Burden of Proof
The potential drawbacks of these devices must, however,
also be considered carefully. The minor disadvantages of
these devices include changes in the nature or order of the
technical steps of the operation to which each surgeon has
become accustomed. For instance, the current generation of
the Symmetry connector requires that proximal anastomo-
ses be constructed before distal anastomoses, that these
anastomoses be circular, and that they arise from the aorta
at a 90° angle. Overcoming these issues is largely a process
of experience, as in learning where to site left-sided proxi-
mal anastomoses to avoid kinking by the pericardium or
pulmonary artery. Surgeons must also learn to pay attention
to characteristics of the conduit or anastomotic target that
may render it unsuitable for use with a device, such as
excessive vein thickness, inadequate diameter, or calcifica-
tion of the aorta or coronary artery. These issues are easily
overcome, however, with a modicum of training and expe-
rience, as reflected in the implantation of tens of thousands
of devices over the last 21⁄2 years.
The more significant concerns regarding such devices
relate to potential early problems with hemostasis, device
dislodgment, or graft occlusion. These issues can be clari-
fied relatively easily, in clinical series with short-term fol-
low-up. Worldwide clinical experience with the Symmetry
system has been generally very favorable, with only very
isolated reports of device-related complications. Nonhemo-
static device deployments are easily remedied with addi-
tional sutures and have been less frequent in our experience
than nonhemostatic hand-sewn anastomoses. A dislodged
connector can be amputated, the vein graft reloaded onto a
new system, and the proximal anastomosis constructed
again without difficulty. Of more concern is the potential for
early graft occlusion, as reported by Donsky and associ-
ates.4 The prevalence of this complication appears to be
extremely low and may be related to a systemic prothrom-
botic state in a small number of patients, but these obser-
vations highlight the fact, among others, that the optimal
antiplatelet regimen after anastomotic device implantation
has not yet been defined.
The greatest issue will be determining the effect of these
devices on long-term graft patency. Given the 35-year track
record of the “current technology,” a substantial burden of
proof exists on proponents of the new technology to dem-
onstrate at least equivalence in late outcomes. These data,
however, are difficult to obtain and require a substantial
investment of time, money, and effort. The most appropriate
substitute is short-term to medium-term evaluation of graft
patency to assess early technical failures and potentially
accelerated intimal hyperplasia. In our initial clinical series
of 25 patients in whom Symmetry connectors were im-
planted, follow-up angiography at 6 to 12 months demon-
strated a reassuring 100% patency of connector vein grafts
(unpublished data). In contrast, the occurrence of late graft
atherosclerosis in connector grafts will not be known for
years but may be less influenced by these devices than early
and midterm modes of graft failure. The demonstration of
comparable midterm graft patency alone may therefore do
much to facilitate the widespread acceptance of these
devices.
Defining a Niche
In this issue of the Journal, Semra´d and colleagues5 report
on their experience with the Symmetry sutureless connector
for proximal vein graft anastomoses in 15 patients under-
going video-assisted on-pump multivessel CABG through a
left anterior small thoracotomy approach, selected for a
variety of indications including coronary reoperation, antic-
ipated sternal fragility, and cosmesis. They report good
clinical outcomes, with no operative mortality. On early
postoperative angiography, 86% of grafts were widely
patent. Two vein grafts were occluded, and one patient, in
whom two graft stenoses were noted, underwent percutane-
ous transluminal coronary angioplasty.
Semra´d and colleagues conclude that this approach rep-
resents a safe alternative to conventional sternotomy in
these selected patients. In this nominally less-invasive ap-
proach, a potential advantage of the sutureless aortic con-
nector system is demonstrated, that is, suitability to minimal
access approaches. Application of the device generally re-
quired insertion of additional ports to obtain the right-
angled access to the ascending aorta that is required for
connector deployment, but this series is a good example of
how these devices can simplify and expedite a “minimally
invasive” operation. This case series, lacking a comparison
group, cannot, however, conclude that the left anterior small
thoracotomy approach reduces complications or length of
stay compared with sternotomy.
This series raises a number of other interesting issues.
The detection of ascending aortic atherosclerosis by preop-
erative echocardiography constituted an exclusion criterion
in this study. However, the aorta with patchy atherosclerosis
(rather than the completely calcified, porcelain variety) may
be the strongest indication for use of this sutureless connec-
tor, as aortic clamping is rendered unnecessary. Because the
1-cm circle of aorta in which the device is deployed should,
however, be reasonably free of atherosclerosis, intraopera-
tive assessment of the aorta by epiaortic echocardiography
is advisable to precisely localize segments of atherosclerotic
versus normal aorta. Graft positioning in reoperations via a
limited-access approach is also critical. The combination of
the 90° proximal anastomosis and limited mediastinal dis-
section may permit less room to position grafts and predis-
pose to graft kinking.
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Future Devices, Future Studies
Anastomotic device technology is evolving rapidly. The
next generations of these devices, for proximal and distal
anastomoses,6 will be significantly easier and quicker to
load and deploy and will permit construction of anastomo-
ses in any order. The ability to instrument the graft only
through the portion to be discarded, rather than the portion
that will remain to serve as a conduit, will minimize the
potential for endothelial injury and lead to greater use of
these devices with arterial conduits. As these devices ma-
ture, it may become possible, in as little as 2 to 3 years, to
perform multivessel CABG, without cardiopulmonary by-
pass, in less than half the time and with significantly less
morbidity than today. The potential of these anastomotic
devices is staggering, although the realization of that poten-
tial will face a number of obstacles.
One challenge facing device engineers may be, in fact, to
limit the perfect reproducibility that has been one of the
most touted advantages of these devices. The tradeoff for
perfect reproducibility of the anastomotic technique is some
loss of flexibility—the bite-by-bite adjustments that sur-
geons make in creating hand-sewn anastomoses to athero-
sclerotic target vessels. The development of devices that can
adapt to, or are tolerant of, local variations in vessel wall
thickness, mural plaques, or calcification will prove increas-
ingly important as patients with progressively more ad-
vanced coronary atherosclerosis are treated.
A number of questions remain to be answered, related
both to safety and to efficacy. Is long-term graft patency
equivalent? Although initial experience with these devices
in hundreds of centers worldwide has been extremely fa-
vorable, longer-term clinical and angiographic follow-up
will be required to ensure that the most important charac-
teristic of our bypass grafts, late patency, is not compro-
mised. What is the optimal antiplatelet regimen after device
implantation? Many centers have empirically prescribed
clopidogrel alone or in combination with aspirin, in a pro-
tocol similar to that used after coronary stent implantation,
but there are as yet no data to validate this approach. Can
these devices be used safely in arterial grafts as the preva-
lence of multiple arterial grafting continues to increase?
Will the purported advantages of OPCAB finally be con-
vincingly demonstrated in patients in whom anastomotic
devices obviate the need for aortic clamping? Will mini-
mally invasive video-assisted CABG become a practical,
2-hour operation? Are these devices cost-effective for cash-
strapped hospitals to use? And last, do previously implanted
devices pose an impediment to the creation of new anasto-
moses at reoperation? Of all of the above questions, this is
the only one to which we can be assured that the answer will
inevitably be found.
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